A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02
Completed · Phase 2
Conditions studied: Systemic Lupus Erythematosus
In brief
This is a continuation study to evaluate the long-term safety and efficacy of LymphoStat-B™ in subjects with SLE disease, that completed study LBSL02 and benefitted from treatment.
Key facts
- Study ID
- NCT00583362
- Run by
- Human Genome Sciences Inc., a GSK Company
- People needed
- 298
- Starts
- 2005-05-04
- Expected to finish
- 2016-02-23
- Last updated by the study team
- 2019-07-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- GSK Investigational Site — Scottsdale, Arizona, United States
- GSK Investigational Site — Tucson, Arizona, United States
- GSK Investigational Site — La Jolla, California, United States
- GSK Investigational Site — Los Angeles, California, United States
- GSK Investigational Site — Los Angeles, California, United States
- GSK Investigational Site — Sacramento, California, United States
- GSK Investigational Site — San Jose, California, United States
- GSK Investigational Site — Upland, California, United States
- GSK Investigational Site — Colorado Springs, Colorado, United States
- GSK Investigational Site — Washington D.C., District of Columbia, United States
- GSK Investigational Site — Aventura, Florida, United States
- GSK Investigational Site — Orlando, Florida, United States
- GSK Investigational Site — Tampa, Florida, United States
- GSK Investigational Site — Atlanta, Georgia, United States
- GSK Investigational Site — Boise, Idaho, United States
- GSK Investigational Site — Idaho Falls, Idaho, United States
- GSK Investigational Site — Chicago, Illinois, United States
- GSK Investigational Site — Chicago, Illinois, United States
- GSK Investigational Site — Munster, Indiana, United States
- GSK Investigational Site — Kansas City, Kansas, United States
- GSK Investigational Site — Louisville, Kentucky, United States
- GSK Investigational Site — Baton Rouge, Louisiana, United States
- GSK Investigational Site — New Orleans, Louisiana, United States
- GSK Investigational Site — Baltimore, Maryland, United States
- GSK Investigational Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.